Guided by the profound vision of former President Dr. Yuan-Tseh Lee and the founding Director Dr. Chi-Huey Wong, the Genomics Research Center (GRC) was established in 2003.
The major focus of GRC’s research is on the understanding of genes associated with diseases and their functions. Through novel discoveries, powerful diagnosis tools and new therapeutic strategies are expected to be developed. Increased efforts will be placed on the pursuit of fundamental scientific advances through interdisciplinary programs, and the extension of basic discoveries to translational research. Therefore, we organize three research Divisions: Chemical Biology to develop new tools and molecules to target cancer and infectious diseases, Medical Biology to develop translational medicine for cancer biology, stem cell biology, immunobiology and epidemiology, and Physical and Computational Genomics to develop data analysis for drug prediction, and novel biomedical technology development. In addition to these Divisions, GRC has also established the Biotechnology Incubation Center (BIC) for pursuing technology transfer to convert important discoveries into commercial opportunities.
Some of the scientific pursuits in GRC with great potential to be among the world leading research include new drug design based on structure study of membrane protein, carbohydrate chemistry and structure biology, the relationship of molecular biology modulation and disease, high throughput technology for drug discovery, infectious disease and vaccine development, immunotherapy, cancer stem cell, epidemiology, evolutionary bioinformatics, biological mass spectrometer development, and fast biomarker search. We continuously strive to make GRC a place that inspires as well as fulfills innovative ideas.
We will continue to pursue fundamental scientific research and translate the discoveries to disease therapeutics through interdisciplinary approaches. Our future perspective is to play a more crucial role in pharmaceutical and biomedical device industry in Taiwan.
